Form 4 for BSX Boston Scientific
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-29 · accession 0001225208-24-006445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-30 | 2024-05-29 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $75.10 | -63.8K | 28.0K | -69% | -$4.79M |
| D | 2024-05-30 | 2024-05-29 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $17.26 | +33.7K | 91.8K | +58% | +$582.1K |
| D | 2024-05-30 | 2024-05-29 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | -33.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | S | D | 63,802 | $75.10 | 28,022 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.78 to $75.33, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-05-29 | M | A | 33,726 | $17.26 | 91,824 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-29 | M | D | 33,726 | $0.00 | 0 | D | $17.26 · — to 2026-02-22 | 33,726 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |